BIOPLUS ACQUISITION CORP's ticker is and the CUSIP is G11217117. A total of 32 filers reported holding BIOPLUS ACQUISITION CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,597,500 | – | 150,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Radcliffe Capital Management, L.P. | 718,701 | $7,790,647 | 0.97% |
| BERKLEY W R CORP | 1,119,638 | $12,125,680 | 0.79% |
| First Trust Capital Management L.P. | 1,106,378 | $11,993,027 | 0.66% |
| COWEN AND COMPANY, LLC | 679,393 | $7,364,552 | 0.52% |
| Westchester Capital Management, LLC | 1,390,000 | $15,053,701 | 0.44% |
| METEORA CAPITAL, LLC | 235,256 | $2,550,152 | 0.44% |
| BCK CAPITAL MANAGEMENT LP | 74,268 | $805,058 | 0.41% |
| Exos TFP Holdings LLC | 60,000 | $650,400 | 0.35% |
| PERISCOPE CAPITAL INC. | 250,000 | $2,709,975 | 0.31% |
| FIR TREE CAPITAL MANAGEMENT LP | 230,111 | $2,492,102 | 0.26% |